Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid

Summary

This is an open-label, proof-of-concept, single group study in adult participants with newly diagnosed, moderate to extensive BP.

Timeline

Start

2016-02-29

Primary completion

2018-04-30

Completion

2018-04-30

Drugs

Indications